2m 2m 2m 2m 2m 2m 2m
Macrogenics (MGNX)
NASDAQ
$2.33-$0.09 (-3.93%)
Price as of Nov 11, 2026 7:04 PM EST- $154.2MMarket Cap
- 59.21%1-Year Change
- BiotechnologyIndustry
Macrogenics (MGNX)
$2.33-$0.09 (-3.93%)
MGNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.42 | ||
Change | +$0.08 (+3.42%) | ||
Open | $2.31 | ||
High | $2.43 | ||
Low | $2.31 | ||
Previous Close | $2.34 | ||
Volume | 468,035 | ||
30-Day Average Volume | 1,003,876 | ||
1-Week Change | 3.86% | ||
1-Month Change | -35.29% | ||
1-Year Change | 59.21% | ||
3-Year Change | -62.19% | ||
5-Year Change | -88.14% | ||
Fundamentals | |||
Shares Outstanding | 63.7M | ||
Total Assets | $345.4M | ||
Market Cap | $154.2M | ||
Enterprise Value | $40.2M | ||
Period: QTR TTM FY | |||
Revenue | $25.5M | ||
Net Income | $19.5M | ||
Free Cash Flow | -$41.6M | ||
EBIT | $23.9M | ||
EBITDA | $24.6M | ||
Net Working Capital | $212.9M | ||
EPS | $0.31 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 4 | ||
P/E | 8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue